These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 21823121)

  • 1. Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
    Hwang-Bo J; Yoo KH; Park JH; Jeong HS; Chung IS
    Int J Cancer; 2012 Jul; 131(2):298-309. PubMed ID: 21823121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-O-Acetyloleanolic acid inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis via suppression of angiopoietin-1/Tie-2 signaling.
    Hwang-Bo J; Park JH; Chung IS
    Phytother Res; 2020 Feb; 34(2):359-367. PubMed ID: 31680342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant canstatin inhibits VEGF-A-induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC-VII animal model.
    Hwang-Bo J; Park JH; Bae MG; Chung IS
    Cancer Med; 2016 Oct; 5(10):2977-2988. PubMed ID: 27650585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
    Chen HM; Tsai CH; Hung WC
    Oncotarget; 2015 Jun; 6(17):14940-52. PubMed ID: 25909285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corosolic Acid Exhibits Anti-angiogenic and Anti-lymphangiogenic Effects on In Vitro Endothelial Cells and on an In Vivo CT-26 Colon Carcinoma Animal Model.
    Yoo KH; Park JH; Lee DY; Hwang-Bo J; Baek NI; Chung IS
    Phytother Res; 2015 May; 29(5):714-23. PubMed ID: 25644809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
    He GA; Luo JX; Zhang TY; Hu ZS; Wang FY
    Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth.
    He GA; Luo JX; Zhang TY; Wang FY; Li RF
    Biochem Biophys Res Commun; 2003 Dec; 312(3):801-5. PubMed ID: 14680836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of antiangiogenic effects of human canstatin with a hypoxia-regulated transgene vector in lung cancer model.
    Li YY; Qian GS; Huang GJ; Chen F; Qian P; Yu SC; Wang CZ; Li Q; Wang JC; Wu GM
    Cancer J; 2006; 12(2):136-46. PubMed ID: 16630405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant mouse canstatin inhibits chicken embryo chorioallantoic membrane angiogenesis and endothelial cell proliferation.
    Hou WH; Wang TY; Yuan BM; Chai YR; Jia YL; Tian F; Wang JM; Xue LX
    Acta Biochim Biophys Sin (Shanghai); 2004 Dec; 36(12):845-50. PubMed ID: 15592653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T11TS inhibits Angiopoietin-1/Tie-2 signaling, EGFR activation and Raf/MEK/ERK pathway in brain endothelial cells restraining angiogenesis in glioma model.
    Bhattacharya D; Chaudhuri S; Singh MK; Chaudhuri S
    Exp Mol Pathol; 2015 Jun; 98(3):455-66. PubMed ID: 25797371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
    Whitehurst B; Flister MJ; Bagaitkar J; Volk L; Bivens CM; Pickett B; Castro-Rivera E; Brekken RA; Gerard RD; Ran S
    Int J Cancer; 2007 Nov; 121(10):2181-91. PubMed ID: 17597103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxysafflor Yellow A Promotes Angiogenesis via the Angiopoietin 1/ Tie-2 Signaling Pathway.
    Chen T; Chen N; Pang N; Xiao L; Li Y; Li R; Luo M; Deng X; Ren M; Wu J; Wang L
    J Vasc Res; 2016; 53(5-6):245-254. PubMed ID: 27894114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant canstatin inhibits tumor growth in an orthotopic AT-84 oral squamous cell carcinoma model.
    Hwang-Bo J; Yoo KH; Jeong HS; Chung IS
    Biotechnol Lett; 2010 Feb; 32(2):189-94. PubMed ID: 19838634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model.
    Hwang-Bo J; Bae MG; Park JH; Chung IS
    BMC Cancer; 2018 Jul; 18(1):714. PubMed ID: 29976150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin inhibits lymphangiogenesis in vitro and in vivo.
    Wang W; Sukamtoh E; Xiao H; Zhang G
    Mol Nutr Food Res; 2015 Dec; 59(12):2345-54. PubMed ID: 26375757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants.
    Stratmann A; Acker T; Burger AM; Amann K; Risau W; Plate KH
    Int J Cancer; 2001 Feb; 91(3):273-82. PubMed ID: 11169947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway.
    Huang B; Lu Y; Gui M; Guan J; Lin M; Zhao J; Mao Q; Lin J
    Biomed Pharmacother; 2021 May; 137():111331. PubMed ID: 33578235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor-angiopoietin chimera with improved properties for therapeutic angiogenesis.
    Anisimov A; Tvorogov D; Alitalo A; Leppänen VM; An Y; Han EC; Orsenigo F; Gaál EI; Holopainen T; Koh YJ; Tammela T; Korpisalo P; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Dejana E; Koh GY; Choi C; Saharinen P; Alitalo K
    Circulation; 2013 Jan; 127(4):424-34. PubMed ID: 23357661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.